Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac potassium + thiocolchicoside versus diclofenac in acute severe low back pain
2025-523153-33-00Phase 3Authorised
- Sponsor
- Verisfield
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of diclofenac potassium + thiocolchicoside, diclofenac and acetaminophen in acute lumbago (2 arms), sponsored by Verisfield. Primary endpoint: Cumulative pain relief over 7 days. Planned start Jun 2026; status: authorised.
02
Drugs
diclofenac potassium + thiocolchicosidediclofenacacetaminophen
03
Conditions
acute lumbago
Beyond the preview
Go deeper on 2025-523153-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523153-33-00.